Revenue: The sum of all revenue fields included for a company's operating activities.
Puma Biotechnology, Inc. (PBYI) had Revenue of $235.64M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
Revenue |
$235.64M |
$21.59M |
|
$62.68M |
|
$172.96M |
|
$203.00M |
|
$32.64M |
|
$-9.97M |
|
$22.67M |
|
$22.67M |
|
$21.59M |
|
$21.59M |
|
$21.59M |
|
$21.59M |
|
$32.64M |
|
$44.16M |
|
47.13M |
|
47.55M |
|
$0.46 |
|
$0.45 |
|
Balance Sheet Financials | |
$156.19M |
|
$0.85M |
|
$74.34M |
|
$230.53M |
|
$99.38M |
|
$65.66M |
|
$77.70M |
|
$177.09M |
|
$53.44M |
|
$-7.43M |
|
$53.44M |
|
47.65M |
|
Cash Flow Statement Financials | |
$27.01M |
|
$-19.12M |
|
-- |
|
$78.79M |
|
$86.68M |
|
$7.88M |
|
$10.25M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.57 |
|
-- |
|
-- |
|
0.55 |
|
1.86 |
|
73.40% |
|
13.85% |
|
13.85% |
|
18.74% |
|
9.62% |
|
9.16% |
|
$26.87M |
|
-- |
|
-- |
|
-- |
|
1.02 |
|
8.85 |
|
4.93 |
|
74.10 |
|
40.40% |
|
-290.63% |
|
9.37% |
|
18.13% |
|
$1.12 |
|
$0.57 |
|
$0.57 |